Sign Up
Stories
Advancements in Alzheimer's and Parkinson's Disease Research
Share
Alpha Cognition's Business Update
AlzeCure's Drug Therapy Focus
Alzheimer's Market Growth Projections
Overview
API
Research collaborations and patents drive advancements in Alzheimer's disease research and treatment. Meilleur Technologies partners with the Young Blood Institute to utilize a novel imaging agent for detecting and preventing Alzheimer's disease, while IRLAB Therapeutics expands patent protection for its drug candidate for Parkinson's disease.
Ask a question
How do these advancements in Alzheimer's and Parkinson's disease research contribute to the broader field of neurodegenerative diseases?
How might the use of NAV-4694 impact the early detection and prevention of Alzheimer's disease?
What are the potential implications of expanding patent protection for pirepemat in the treatment of Parkinson's disease?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Coverage